Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection.

Cabral-Miranda G, Lim SM, Mohsen MO, Pobelov IV, Roesti ES, Heath MD, Skinner MA, Kramer MF, Martina BEE, Bachmann MF.

Vaccines (Basel). 2019 Jul 23;7(3). pii: E72. doi: 10.3390/vaccines7030072.

2.

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines.

Cabral-Miranda G, M Salman A, O Mohsen M, L Storni F, S Roesti E, A Skinner M, D Heath M, F Kramer M, M Khan S, J Janse C, V S Hill A, F Bachmann M.

Diseases. 2018 Nov 21;6(4). pii: E107. doi: 10.3390/diseases6040107.

Supplemental Content

Loading ...
Support Center